Outlook Therapeutics, Inc. (OTLK) Capital expenditures 2016–2020
Outlook Therapeutics, Inc. (OTLK) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$437,307FY2020 · since FY2016: $8.8M → $437,307
| Fiscal year | Value | YoY |
|---|---|---|
| FY2020 | $437,307 | -84.3% |
| FY2019 | $2.8M | +852.2% |
| FY2018 | $292,086 | -73.4% |
| FY2017 | $1.1M | -87.5% |
| FY2016 | $8.8M | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice